Roche sees positive results for new multiple sclerosis drug in late-stage trials
About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.
About 1 million people are living with multiple sclerosis in the U.S., and about 10% of those have PPMS, making it the least common form of the disease.
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
The test—developed in collaboration with Eli Lilly and Co.—does not diagnose Alzheimer’s but is designed to rule out the presence of the disease’s pathology early on, or indicate further diagnostics are needed.
The new vitamin D test, to be distributed from the Swiss-based company’s Indianapolis hub, is the first such test using a mass spectrometry-based system to receive regulatory approval in the U.S.
The new late-stage study will focus on people who are at risk of cognitive decline.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
Roche said Indiana would receive a new manufacturing facility for continuous glucose monitoring and expansion and upgrades at existing pharmaceutical, diagnostics and distribution operations.
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
Jenn Wells, an executive at the Greenfield-based health care system, is trying to make difficult conversations more accessible through a women’s health podcast she started last fall called “Just Jenn.”
She and her husband, Robert, purchased the company in 1997, but she worked her way up the corporate ladder before taking on an official role.
Republic Airways president Matt Koscal has been with the company since 2014, serving in several positions.
Indianapolis voters need the ability to send a representative to Congress who will advocate for the city, its people and the many corporate headquarters—Eli Lilly and Co., Elevance Health, Roche Diagnostics, Corteva, Simon Property Group and others—located here.
Small businesses are being impacted by economic instability, despite national predictions that call for record spending at small businesses this holiday season.
The Transportation Department proposal represents the administration’s latest bid to unwind a suite of policies spurring electric vehicle production that Trump has derided as an “EV mandate.”
They’ve led teams, managed resources and operated as part of a mission-driven enterprise united by a passion to serve.
If nobody bet on sports, Indianapolis might still have an NBA franchise named the Olympians. Then again, if nobody bet on sports, the city might not have the Indiana Pacers today.
President Donald Trump’s announcement that his administration will impose a 100 percent tariff on patented pharmaceutical products sparked confusion Friday, as government officials, drug companies and trade groups sought clarity on how the levy would be applied.
Trump said on Truth Social that the pharmaceutical tariffs would not apply to companies that are building manufacturing plants in the United States, which he defined as either “breaking ground” or being “under construction.”
The goal of the National Science Foundation’s Engines program is to grow regional innovation ecosystems.
TreeRunner Adventure Parks plans to operate an aerial adventure park on a five-acre wooded area at the center of Grand Park.